Literature DB >> 3755717

Oxygen and nitroreductase-dependent binding of AF-2 in spheroids and murine tumors.

P L Olive, D J Chaplin.   

Abstract

Fluorescent nitroheterocycles such as AF-2 may be useful in identifying hypoxic cells in tumors. Since binding is dependent on rate of drug metabolism (nitroreduction) as well as cellular oxygen content, flow cytometric analysis of cells from tumors and spheroids was used to quantify AF-2 binding, and differential pulse polarography was used to measure reduction of AF-2 by several mammalian cell lines, spheroids and tumor cells. Hypoxic V79 spheroid cells and Lewis lung tumor cells bound 20 times more AF-2 than oxic cells, and binding proceeded with first order kinetics. Nitroreductase activity varied about tenfold among different tumor cells. As expected, the rate of binding of AF-2 correlated well with the rate of nitroreduction. Oral injection of AF-2 (5 mg) was the most successful method of administration to tumor-bearing mice. In mice injected with both AF-2 and Hoechst 33342 (which stains well-perfused cells), SCCVII tumor cells which contained the most Hoechst contained the least AF-2. Although minimal toxicity by AF-2 was observed in these tumors, binding of AF-2 was barely sufficient for detection using flow cytometry.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755717     DOI: 10.1016/0360-3016(86)90269-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

Review 1.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Hydroethidine: a fluorescent redox probe for locating hypoxic cells in spheroids and murine tumours.

Authors:  P L Olive
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

3.  Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenation.

Authors:  R E Durand; P L Olive
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.